Grant: Proof of Principle Program - Phase I
Université Laval
$160,000.00
First-in-class Therapeutic Against Urinary Retention (Continence) in Patients with Chronic Spinal Cord Injury and Related Disorders
EF 2011-12
Résumé
The number of patients currently living with a spinal cord injury (SCI) has importantly increased in recent years. In fact, SCI (1.3 M) has become the second most common neurological problem in North America after Alzheimer (4 M). No cure that can repair SCI has been found. SCI patients suffer of an immediate and irreversible loss of muscle control and sensation as well as other complications including bladder problems. For incompletely understood reasons, they encounter problems to urinate leading to bladder distention, pain, infection and possibly death. Currently used approaches such as catheters are generally considered as improper and dangerous. Our goal is to find a drug therapy, ideally taken orally, that can be used by SCI patients to eliminate or reduce the reliance on catheters and other poorly suitable methods. We already identified 5 promising classes of drugs (molecules) that can reflexively trigger 'automatically' some urination in paraplegic mice. This proposal aims to conduct experiments that will enable the identification of an optimal treatment suitable for further development. Data to be obtained here will be pivotal also for patenting this discovery.
Programme
Proof of Principle Program - Phase I
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
240662
Name
Guertin Pierre
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Proof of Principle
Projecttitle
First-in-class Therapeutic Against Urinary Retention (Continence) in Patients with Chronic Spinal Cord Injury and Related Disorders
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$160,000
Cihrequipment2
$0
Programname2
Proof of Principle Program - Phase I
Keyworddelim
Animal Model; Behavioral Assessment; Chronic Treatment; First-In-Class Drug Treatment; Multibillion Dollars Market; Pharmacological Approach; Spinal Cord Injury; Spinal Micturition Center; Urinary Retention
Abstract
The number of patients currently living with a spinal cord injury (SCI) has importantly increased in recent years. In fact, SCI (1.3 M) has become the second most common neurological problem in North America after Alzheimer (4 M). No cure that can repair SCI has been found. SCI patients suffer of an immediate and irreversible loss of muscle control and sensation as well as other complications including bladder problems. For incompletely understood reasons, they encounter problems to urinate leading to bladder distention, pain, infection and possibly death. Currently used approaches such as catheters are generally considered as improper and dangerous. Our goal is to find a drug therapy, ideally taken orally, that can be used by SCI patients to eliminate or reduce the reliance on catheters and other poorly suitable methods. We already identified 5 promising classes of drugs (molecules) that can reflexively trigger 'automatically' some urination in paraplegic mice. This proposal aims to conduct experiments that will enable the identification of an optimal treatment suitable for further development. Data to be obtained here will be pivotal also for patenting this discovery.
Competitiondate
201109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guertin, Pierre
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $160,000~ $0~